甲状腺功能障碍和肺动脉高血压:一个双向的门德尔随机化研究
Gongli Pang1, Xiaoxia Wang2, Ru Zhao1
1Department of Cardiology, Shanxi Cardiovascular Hospital, Taiyuan, Shanxi, China.
甲状腺功能低下症与肺动脉高血压 (PAH) 的风险增加有关. 这项研究使用门德尔随机化来调查甲状腺功能障碍和PAH之间的关联,没有发现反向因果关系.
科学领域:
- 心血管医学 心血管医学
- 内分泌学 在内分泌学.
- 遗传流行病学遗传流行病学
背景情况:
- 甲状腺功能障碍与心血管疾病有关.
- 甲状腺功能障碍与肺动脉高血压 (PAH) 风险增加之间存在潜在的联系.
- 这种关联的因果性需要调查.
研究的目的:
- 调查甲状腺功能障碍和PAH之间的因果关系.
- 使用双向双样本的门德尔随机化 (MR) 分析.
主要方法:
- 暴露因素包括甲状腺功能障碍标志物 (FT3,FT4,TSH,甲状腺功能过高,甲状腺功能低下).
- 肺动脉高血压 (PAH) 是结果因素.
- 使用反向变量权重 (IVW),MR-Egger和权重中位数方法分析了双向因果关系,评估了异质性和性.
主要成果:
- 甲状腺功能低下症显著增加了PAH风险 (OR = 1.485,P = 0.025).
- 自由三甲状腺素 (FT3),自由甲状腺素 (FT4),甲状腺激素 (TSH) 和甲状腺功能障碍症与PAH风险没有关联.
- 没有发现PAH与甲状腺功能障碍的逆因果关系的证据.
结论:
- 甲状腺功能低下症与肺动脉高血压 (PAH) 的风险增加有关.
- 需要进一步的研究来阐明甲状腺功能障碍和PAH之间的复杂关系.
更多相关视频
10:20Right Ventricular Systolic Pressure Measurements in Combination with Harvest of Lung and Immune Tissue Samples in Mice
Published on: January 16, 2013
07:11Establishment and Validation of a Rat Model of Pulmonary Arterial Hypertension Associated with Pulmonary Fibrosis
Published on: May 23, 2025
相关概念视频
Pulmonary Hypertension: Classification and Pathogenesis
There are various classifications for PH, each relating to different underlying causes and also...
Treatment for Pulmonary Arterial Hypertension: Receptor Tyrosine Kinase Inhibitors and Calcium Channel Blockers
TKIs, such as imatinib (Gleevec), are particularly effective in tackling the growth and mitogenic factors that become upregulated in PAH patients. These factors contribute to the...
Treatment for Pulmonary Arterial Hypertension: Endothelin Receptor Antagonists
ETs are synthesized through a complex sequence of enzymatic steps, primarily involving an enzyme referred to as endothelin-converting enzyme...
Treatment for Pulmonary Arterial Hypertension: Phosphodiesterase Inhibitors
Among the PDE5 inhibitors, sildenafil (Revatio) stands out as a competitive and selective inhibitor. It operates by elevating cellular levels of cGMP and augmenting signaling through the cGMP-PKG pathway, promoting vasodilation. Upon oral...
Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
Medical History
Hypertension II: Pathophysiology
